Ascentage Pharma Group International (AAPG) Total Liabilities (2023 - 2025)

Ascentage Pharma Group International's Total Liabilities history runs 3 years deep, the most recent figure standing at $370.7 million for Q4 2025.

• In Q4 2025, Total Liabilities rose 13.62% year-over-year to $370.7 million; the TTM figure through Dec 2025 stood at $370.7 million (up 13.62% YoY), while the FY2025 annual figure was $376.0 million, up 17.1% from the prior year.
• Total Liabilities for Q4 2025 stood at $370.7 million, down from $425.2 million in the prior quarter.
• The five-year high for Total Liabilities was $425.2 million in Q2 2025, with the low at $326.3 million in Q4 2024.
• The 3-year median for Total Liabilities is $354.1 million (2023), against an average of $364.9 million.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities slipped 3.32% in 2024, then increased 13.62% in 2025.
• Ascentage Pharma Group International's Total Liabilities stood at $337.5 million in 2023, then decreased by 3.32% to $326.3 million in 2024, then climbed by 13.62% to $370.7 million in 2025.
• Business Quant data shows AAPG's Total Liabilities at $370.7 million in Q4 2025, $425.2 million in Q2 2025, and $326.3 million in Q4 2024.